Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-25 @ 4:30 AM
NCT ID:
NCT03622918
Eligibility Criteria:
Inclusion Criteria:
* Pneumonia, blood septicemia, urinary tract infection, or other infection or even colonization with evidence of extensively drug-resistant Acinetobacter baumannii infection
Exclusion Criteria:
* Hypersensitivity reaction to colistin or rifampin
* use of colistin or rifampin in 15 days prior to screening
* evidence of extensively drug-resistant Acinetobacter baumannii infection in 15 days prior to screening
* CLcr \< 15 mL/min, ALT or AST \> 3xULN, total bilirubin \> 2xULN, Hb \< 7 gm/dL, ANC \< 500/mm3, Platelet \< 50,000/mm3
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT03622918
Study Brief:
Protocol Section:
NCT03622918